nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—BCHE—malignant glioma	0.616	1	CbGaD
Galantamine—CHRNB3—pons—malignant glioma	0.0238	0.162	CbGeAlD
Galantamine—CHRNA9—embryo—malignant glioma	0.00874	0.0593	CbGeAlD
Galantamine—CHRNA4—telencephalic ventricle—malignant glioma	0.00588	0.0399	CbGeAlD
Galantamine—CHRNB3—brainstem—malignant glioma	0.00531	0.036	CbGeAlD
Galantamine—Ethylmorphine—POR—malignant glioma	0.00508	0.737	CrCbGaD
Galantamine—CHRNB3—telencephalon—malignant glioma	0.00471	0.032	CbGeAlD
Galantamine—CHRNA6—brainstem—malignant glioma	0.00443	0.0301	CbGeAlD
Galantamine—Paranoid reaction—Carmustine—malignant glioma	0.00424	0.0302	CcSEcCtD
Galantamine—CHRNA6—telencephalon—malignant glioma	0.00393	0.0267	CbGeAlD
Galantamine—Disorder sight—Temozolomide—malignant glioma	0.00366	0.0261	CcSEcCtD
Galantamine—Transient ischaemic attack—Temozolomide—malignant glioma	0.00345	0.0246	CcSEcCtD
Galantamine—CHRNB3—midbrain—malignant glioma	0.00338	0.0229	CbGeAlD
Galantamine—CHRNA5—central nervous system—malignant glioma	0.00295	0.02	CbGeAlD
Galantamine—CHRNG—medulla oblongata—malignant glioma	0.00291	0.0198	CbGeAlD
Galantamine—CHRNA6—midbrain—malignant glioma	0.00282	0.0192	CbGeAlD
Galantamine—Aphasia—Carmustine—malignant glioma	0.00278	0.0198	CcSEcCtD
Galantamine—Aphasia—Temozolomide—malignant glioma	0.00268	0.0191	CcSEcCtD
Galantamine—CHRNB3—central nervous system—malignant glioma	0.00268	0.0182	CbGeAlD
Galantamine—Hypokinesia—Carmustine—malignant glioma	0.00267	0.019	CcSEcCtD
Galantamine—CHRNG—midbrain—malignant glioma	0.00266	0.0181	CbGeAlD
Galantamine—Paranoia—Carmustine—malignant glioma	0.00264	0.0188	CcSEcCtD
Galantamine—CHRNB3—cerebellum—malignant glioma	0.00262	0.0178	CbGeAlD
Galantamine—Apathy—Temozolomide—malignant glioma	0.00244	0.0174	CcSEcCtD
Galantamine—Flat affect—Temozolomide—malignant glioma	0.00242	0.0172	CcSEcCtD
Galantamine—CHRNA3—retina—malignant glioma	0.00238	0.0162	CbGeAlD
Galantamine—CHRNA5—brain—malignant glioma	0.00234	0.0159	CbGeAlD
Galantamine—CHRNB2—telencephalon—malignant glioma	0.00226	0.0153	CbGeAlD
Galantamine—Coagulopathy—Temozolomide—malignant glioma	0.00224	0.0159	CcSEcCtD
Galantamine—CHRNA6—central nervous system—malignant glioma	0.00223	0.0152	CbGeAlD
Galantamine—CHRNA6—cerebellum—malignant glioma	0.00218	0.0148	CbGeAlD
Galantamine—CHRNB3—brain—malignant glioma	0.00213	0.0144	CbGeAlD
Galantamine—CHRNB4—central nervous system—malignant glioma	0.00203	0.0138	CbGeAlD
Galantamine—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00184	0.0131	CcSEcCtD
Galantamine—Ethylmorphine—CYP2B6—malignant glioma	0.00182	0.263	CrCbGaD
Galantamine—CHRNB2—medulla oblongata—malignant glioma	0.00177	0.012	CbGeAlD
Galantamine—CHRNA6—brain—malignant glioma	0.00177	0.012	CbGeAlD
Galantamine—CHRFAM7A—telencephalon—malignant glioma	0.00177	0.012	CbGeAlD
Galantamine—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00174	0.0124	CcSEcCtD
Galantamine—Urinary incontinence—Carmustine—malignant glioma	0.00174	0.0124	CcSEcCtD
Galantamine—Urinary incontinence—Temozolomide—malignant glioma	0.00168	0.012	CcSEcCtD
Galantamine—ACHE—telencephalon—malignant glioma	0.00164	0.0111	CbGeAlD
Galantamine—CHRNB2—midbrain—malignant glioma	0.00162	0.011	CbGeAlD
Galantamine—CHRNB4—brain—malignant glioma	0.00161	0.0109	CbGeAlD
Galantamine—CHRNA4—brainstem—malignant glioma	0.00159	0.0108	CbGeAlD
Galantamine—CHRNB2—spinal cord—malignant glioma	0.00158	0.0107	CbGeAlD
Galantamine—CHRNA7—retina—malignant glioma	0.00155	0.0105	CbGeAlD
Galantamine—CHRNB1—medulla oblongata—malignant glioma	0.00149	0.0101	CbGeAlD
Galantamine—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00145	0.0104	CcSEcCtD
Galantamine—CHRNA7—telencephalon—malignant glioma	0.00143	0.0097	CbGeAlD
Galantamine—Gastroenteritis—Temozolomide—malignant glioma	0.00143	0.0102	CcSEcCtD
Galantamine—Injury—Carmustine—malignant glioma	0.00142	0.0101	CcSEcCtD
Galantamine—Vascular purpura—Temozolomide—malignant glioma	0.00141	0.0101	CcSEcCtD
Galantamine—CHRNA4—telencephalon—malignant glioma	0.00141	0.00957	CbGeAlD
Galantamine—CHRNB1—midbrain—malignant glioma	0.00136	0.00923	CbGeAlD
Galantamine—CHRNB1—spinal cord—malignant glioma	0.00133	0.009	CbGeAlD
Galantamine—Purpura—Temozolomide—malignant glioma	0.00131	0.00935	CcSEcCtD
Galantamine—ACHE—medulla oblongata—malignant glioma	0.00129	0.00875	CbGeAlD
Galantamine—CHRNB2—central nervous system—malignant glioma	0.00128	0.00871	CbGeAlD
Galantamine—CHRNB2—cerebellum—malignant glioma	0.00125	0.00851	CbGeAlD
Galantamine—CHRNA3—central nervous system—malignant glioma	0.00124	0.00844	CbGeAlD
Galantamine—Ataxia—Carmustine—malignant glioma	0.00123	0.00877	CcSEcCtD
Galantamine—CHRNA3—cerebellum—malignant glioma	0.00122	0.00825	CbGeAlD
Galantamine—Hypokalaemia—Carmustine—malignant glioma	0.00119	0.00849	CcSEcCtD
Galantamine—Ataxia—Temozolomide—malignant glioma	0.00119	0.00847	CcSEcCtD
Galantamine—ACHE—midbrain—malignant glioma	0.00118	0.008	CbGeAlD
Galantamine—Dehydration—Temozolomide—malignant glioma	0.00118	0.00838	CcSEcCtD
Galantamine—CHRNA2—central nervous system—malignant glioma	0.00116	0.00785	CbGeAlD
Galantamine—Muscular weakness—Carmustine—malignant glioma	0.00115	0.00822	CcSEcCtD
Galantamine—ACHE—spinal cord—malignant glioma	0.00115	0.00781	CbGeAlD
Galantamine—Hypokalaemia—Temozolomide—malignant glioma	0.00115	0.0082	CcSEcCtD
Galantamine—CHRNA2—cerebellum—malignant glioma	0.00113	0.00767	CbGeAlD
Galantamine—Dysphagia—Carmustine—malignant glioma	0.00113	0.00806	CcSEcCtD
Galantamine—Muscular weakness—Temozolomide—malignant glioma	0.00111	0.00795	CcSEcCtD
Galantamine—CHRNA1—brain—malignant glioma	0.00111	0.00751	CbGeAlD
Galantamine—Dysphagia—Temozolomide—malignant glioma	0.00109	0.00779	CcSEcCtD
Galantamine—CHRNB1—cerebellum—malignant glioma	0.00105	0.00714	CbGeAlD
Galantamine—Bronchitis—Temozolomide—malignant glioma	0.00105	0.00749	CcSEcCtD
Galantamine—Hyperglycaemia—Carmustine—malignant glioma	0.00102	0.00727	CcSEcCtD
Galantamine—CHRNB2—brain—malignant glioma	0.00102	0.00691	CbGeAlD
Galantamine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00102	0.00724	CcSEcCtD
Galantamine—Pneumonia—Carmustine—malignant glioma	0.00101	0.00723	CcSEcCtD
Galantamine—CHRNA4—midbrain—malignant glioma	0.00101	0.00687	CbGeAlD
Galantamine—Pollakiuria—Temozolomide—malignant glioma	0.00101	0.00719	CcSEcCtD
Galantamine—CHRFAM7A—central nervous system—malignant glioma	0.00101	0.00683	CbGeAlD
Galantamine—Depression—Carmustine—malignant glioma	0.00101	0.00716	CcSEcCtD
Galantamine—Renal failure—Carmustine—malignant glioma	0.000991	0.00706	CcSEcCtD
Galantamine—CHRNA4—spinal cord—malignant glioma	0.000989	0.00671	CbGeAlD
Galantamine—Weight decreased—Temozolomide—malignant glioma	0.000988	0.00705	CcSEcCtD
Galantamine—CHRNA3—brain—malignant glioma	0.000988	0.0067	CbGeAlD
Galantamine—Neuropathy peripheral—Carmustine—malignant glioma	0.000988	0.00704	CcSEcCtD
Galantamine—Hyperglycaemia—Temozolomide—malignant glioma	0.000985	0.00703	CcSEcCtD
Galantamine—Urinary tract infection—Carmustine—malignant glioma	0.00098	0.00698	CcSEcCtD
Galantamine—Pneumonia—Temozolomide—malignant glioma	0.00098	0.00698	CcSEcCtD
Galantamine—Depression—Temozolomide—malignant glioma	0.000971	0.00692	CcSEcCtD
Galantamine—Neuropathy peripheral—Temozolomide—malignant glioma	0.000955	0.00681	CcSEcCtD
Galantamine—Urinary tract infection—Temozolomide—malignant glioma	0.000947	0.00675	CcSEcCtD
Galantamine—Hepatobiliary disease—Temozolomide—malignant glioma	0.000921	0.00657	CcSEcCtD
Galantamine—CHRNA2—brain—malignant glioma	0.000919	0.00623	CbGeAlD
Galantamine—ACHE—cerebellum—malignant glioma	0.000912	0.00619	CbGeAlD
Galantamine—BCHE—brainstem—malignant glioma	0.00091	0.00617	CbGeAlD
Galantamine—Haemoglobin—Carmustine—malignant glioma	0.000909	0.00648	CcSEcCtD
Galantamine—Haemorrhage—Carmustine—malignant glioma	0.000905	0.00645	CcSEcCtD
Galantamine—Hallucination—Carmustine—malignant glioma	0.0009	0.00642	CcSEcCtD
Galantamine—Oedema peripheral—Carmustine—malignant glioma	0.000891	0.00635	CcSEcCtD
Galantamine—Connective tissue disorder—Carmustine—malignant glioma	0.000889	0.00634	CcSEcCtD
Galantamine—Haemoglobin—Temozolomide—malignant glioma	0.000879	0.00627	CcSEcCtD
Galantamine—Haemorrhage—Temozolomide—malignant glioma	0.000874	0.00623	CcSEcCtD
Galantamine—Hepatitis—Temozolomide—malignant glioma	0.000874	0.00623	CcSEcCtD
Galantamine—Visual impairment—Carmustine—malignant glioma	0.000872	0.00622	CcSEcCtD
Galantamine—Hallucination—Temozolomide—malignant glioma	0.00087	0.0062	CcSEcCtD
Galantamine—Urinary tract disorder—Temozolomide—malignant glioma	0.000864	0.00616	CcSEcCtD
Galantamine—Oedema peripheral—Temozolomide—malignant glioma	0.000861	0.00614	CcSEcCtD
Galantamine—Connective tissue disorder—Temozolomide—malignant glioma	0.000859	0.00613	CcSEcCtD
Galantamine—Urethral disorder—Temozolomide—malignant glioma	0.000857	0.00611	CcSEcCtD
Galantamine—CHRNB1—brain—malignant glioma	0.000855	0.0058	CbGeAlD
Galantamine—Eye disorder—Carmustine—malignant glioma	0.000846	0.00603	CcSEcCtD
Galantamine—Visual impairment—Temozolomide—malignant glioma	0.000843	0.00601	CcSEcCtD
Galantamine—Flushing—Carmustine—malignant glioma	0.00084	0.00599	CcSEcCtD
Galantamine—Eye disorder—Temozolomide—malignant glioma	0.000817	0.00583	CcSEcCtD
Galantamine—Tinnitus—Temozolomide—malignant glioma	0.000815	0.00581	CcSEcCtD
Galantamine—CHRNA7—central nervous system—malignant glioma	0.000813	0.00552	CbGeAlD
Galantamine—Cardiac disorder—Temozolomide—malignant glioma	0.000812	0.00579	CcSEcCtD
Galantamine—Flushing—Temozolomide—malignant glioma	0.000812	0.00579	CcSEcCtD
Galantamine—Arrhythmia—Carmustine—malignant glioma	0.000808	0.00576	CcSEcCtD
Galantamine—BCHE—telencephalon—malignant glioma	0.000807	0.00548	CbGeAlD
Galantamine—CHRNA4—central nervous system—malignant glioma	0.000802	0.00544	CbGeAlD
Galantamine—CHRFAM7A—brain—malignant glioma	0.000799	0.00542	CbGeAlD
Galantamine—Angiopathy—Temozolomide—malignant glioma	0.000793	0.00566	CcSEcCtD
Galantamine—Mental disorder—Carmustine—malignant glioma	0.000793	0.00565	CcSEcCtD
Galantamine—Immune system disorder—Temozolomide—malignant glioma	0.00079	0.00563	CcSEcCtD
Galantamine—Malnutrition—Carmustine—malignant glioma	0.000788	0.00562	CcSEcCtD
Galantamine—CHRNA4—cerebellum—malignant glioma	0.000784	0.00532	CbGeAlD
Galantamine—Mental disorder—Temozolomide—malignant glioma	0.000766	0.00546	CcSEcCtD
Galantamine—Back pain—Carmustine—malignant glioma	0.000762	0.00543	CcSEcCtD
Galantamine—Malnutrition—Temozolomide—malignant glioma	0.000761	0.00543	CcSEcCtD
Galantamine—Dysgeusia—Temozolomide—malignant glioma	0.000745	0.00531	CcSEcCtD
Galantamine—Vision blurred—Carmustine—malignant glioma	0.000742	0.00529	CcSEcCtD
Galantamine—ACHE—brain—malignant glioma	0.000741	0.00503	CbGeAlD
Galantamine—Tremor—Carmustine—malignant glioma	0.000738	0.00526	CcSEcCtD
Galantamine—Back pain—Temozolomide—malignant glioma	0.000736	0.00525	CcSEcCtD
Galantamine—Anaemia—Carmustine—malignant glioma	0.000728	0.00519	CcSEcCtD
Galantamine—Agitation—Carmustine—malignant glioma	0.000724	0.00516	CcSEcCtD
Galantamine—Vision blurred—Temozolomide—malignant glioma	0.000717	0.00511	CcSEcCtD
Galantamine—Tremor—Temozolomide—malignant glioma	0.000713	0.00508	CcSEcCtD
Galantamine—Ill-defined disorder—Temozolomide—malignant glioma	0.000706	0.00503	CcSEcCtD
Galantamine—Anaemia—Temozolomide—malignant glioma	0.000704	0.00502	CcSEcCtD
Galantamine—Agitation—Temozolomide—malignant glioma	0.0007	0.00499	CcSEcCtD
Galantamine—Malaise—Temozolomide—malignant glioma	0.000686	0.00489	CcSEcCtD
Galantamine—Vertigo—Temozolomide—malignant glioma	0.000684	0.00488	CcSEcCtD
Galantamine—Convulsion—Carmustine—malignant glioma	0.000682	0.00487	CcSEcCtD
Galantamine—Hypertension—Carmustine—malignant glioma	0.00068	0.00485	CcSEcCtD
Galantamine—Palpitations—Temozolomide—malignant glioma	0.000673	0.0048	CcSEcCtD
Galantamine—Chest pain—Carmustine—malignant glioma	0.000671	0.00478	CcSEcCtD
Galantamine—Myalgia—Carmustine—malignant glioma	0.000671	0.00478	CcSEcCtD
Galantamine—Anxiety—Carmustine—malignant glioma	0.000668	0.00476	CcSEcCtD
Galantamine—Cough—Temozolomide—malignant glioma	0.000664	0.00474	CcSEcCtD
Galantamine—Convulsion—Temozolomide—malignant glioma	0.00066	0.0047	CcSEcCtD
Galantamine—Hypertension—Temozolomide—malignant glioma	0.000657	0.00469	CcSEcCtD
Galantamine—Confusional state—Carmustine—malignant glioma	0.000648	0.00462	CcSEcCtD
Galantamine—Myalgia—Temozolomide—malignant glioma	0.000648	0.00462	CcSEcCtD
Galantamine—Arthralgia—Temozolomide—malignant glioma	0.000648	0.00462	CcSEcCtD
Galantamine—Anxiety—Temozolomide—malignant glioma	0.000646	0.0046	CcSEcCtD
Galantamine—CHRNA7—brain—malignant glioma	0.000645	0.00438	CbGeAlD
Galantamine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000644	0.00459	CcSEcCtD
Galantamine—Discomfort—Temozolomide—malignant glioma	0.00064	0.00456	CcSEcCtD
Galantamine—CHRNA4—brain—malignant glioma	0.000637	0.00432	CbGeAlD
Galantamine—BCHE—medulla oblongata—malignant glioma	0.000634	0.0043	CbGeAlD
Galantamine—Dry mouth—Temozolomide—malignant glioma	0.000634	0.00452	CcSEcCtD
Galantamine—Thrombocytopenia—Carmustine—malignant glioma	0.000629	0.00449	CcSEcCtD
Galantamine—Tachycardia—Carmustine—malignant glioma	0.000627	0.00447	CcSEcCtD
Galantamine—Confusional state—Temozolomide—malignant glioma	0.000626	0.00447	CcSEcCtD
Galantamine—Anorexia—Carmustine—malignant glioma	0.000613	0.00437	CcSEcCtD
Galantamine—Nervous system disorder—Temozolomide—malignant glioma	0.000609	0.00434	CcSEcCtD
Galantamine—Thrombocytopenia—Temozolomide—malignant glioma	0.000608	0.00434	CcSEcCtD
Galantamine—Skin disorder—Temozolomide—malignant glioma	0.000603	0.0043	CcSEcCtD
Galantamine—CYP2D6—brainstem—malignant glioma	0.000603	0.00409	CbGeAlD
Galantamine—Hypotension—Carmustine—malignant glioma	0.000601	0.00428	CcSEcCtD
Galantamine—Hyperhidrosis—Temozolomide—malignant glioma	0.000601	0.00428	CcSEcCtD
Galantamine—Anorexia—Temozolomide—malignant glioma	0.000592	0.00422	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000586	0.00418	CcSEcCtD
Galantamine—Insomnia—Carmustine—malignant glioma	0.000581	0.00415	CcSEcCtD
Galantamine—BCHE—midbrain—malignant glioma	0.00058	0.00393	CbGeAlD
Galantamine—Paraesthesia—Carmustine—malignant glioma	0.000577	0.00412	CcSEcCtD
Galantamine—Somnolence—Carmustine—malignant glioma	0.000572	0.00407	CcSEcCtD
Galantamine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000566	0.00403	CcSEcCtD
Galantamine—BCHE—spinal cord—malignant glioma	0.000566	0.00384	CbGeAlD
Galantamine—Insomnia—Temozolomide—malignant glioma	0.000562	0.00401	CcSEcCtD
Galantamine—Decreased appetite—Carmustine—malignant glioma	0.000559	0.00398	CcSEcCtD
Galantamine—Paraesthesia—Temozolomide—malignant glioma	0.000558	0.00398	CcSEcCtD
Galantamine—Gastrointestinal disorder—Carmustine—malignant glioma	0.000555	0.00396	CcSEcCtD
Galantamine—Somnolence—Temozolomide—malignant glioma	0.000552	0.00394	CcSEcCtD
Galantamine—Constipation—Carmustine—malignant glioma	0.00055	0.00392	CcSEcCtD
Galantamine—Dyspepsia—Temozolomide—malignant glioma	0.000547	0.0039	CcSEcCtD
Galantamine—Decreased appetite—Temozolomide—malignant glioma	0.00054	0.00385	CcSEcCtD
Galantamine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000536	0.00382	CcSEcCtD
Galantamine—Fatigue—Temozolomide—malignant glioma	0.000536	0.00382	CcSEcCtD
Galantamine—CYP2D6—telencephalon—malignant glioma	0.000535	0.00363	CbGeAlD
Galantamine—Constipation—Temozolomide—malignant glioma	0.000531	0.00379	CcSEcCtD
Galantamine—Feeling abnormal—Carmustine—malignant glioma	0.00053	0.00378	CcSEcCtD
Galantamine—Gastrointestinal pain—Carmustine—malignant glioma	0.000526	0.00375	CcSEcCtD
Galantamine—Feeling abnormal—Temozolomide—malignant glioma	0.000512	0.00365	CcSEcCtD
Galantamine—Body temperature increased—Carmustine—malignant glioma	0.000508	0.00362	CcSEcCtD
Galantamine—Abdominal pain—Carmustine—malignant glioma	0.000508	0.00362	CcSEcCtD
Galantamine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000508	0.00362	CcSEcCtD
Galantamine—Abdominal pain—Temozolomide—malignant glioma	0.000491	0.0035	CcSEcCtD
Galantamine—Body temperature increased—Temozolomide—malignant glioma	0.000491	0.0035	CcSEcCtD
Galantamine—Hypersensitivity—Carmustine—malignant glioma	0.000474	0.00338	CcSEcCtD
Galantamine—Asthenia—Carmustine—malignant glioma	0.000461	0.00329	CcSEcCtD
Galantamine—BCHE—central nervous system—malignant glioma	0.000459	0.00311	CbGeAlD
Galantamine—Hypersensitivity—Temozolomide—malignant glioma	0.000458	0.00326	CcSEcCtD
Galantamine—BCHE—cerebellum—malignant glioma	0.000448	0.00304	CbGeAlD
Galantamine—Asthenia—Temozolomide—malignant glioma	0.000446	0.00318	CcSEcCtD
Galantamine—Diarrhoea—Carmustine—malignant glioma	0.00044	0.00314	CcSEcCtD
Galantamine—Dizziness—Carmustine—malignant glioma	0.000425	0.00303	CcSEcCtD
Galantamine—Diarrhoea—Temozolomide—malignant glioma	0.000425	0.00303	CcSEcCtD
Galantamine—Dizziness—Temozolomide—malignant glioma	0.000411	0.00293	CcSEcCtD
Galantamine—Vomiting—Carmustine—malignant glioma	0.000409	0.00291	CcSEcCtD
Galantamine—Rash—Carmustine—malignant glioma	0.000405	0.00289	CcSEcCtD
Galantamine—Dermatitis—Carmustine—malignant glioma	0.000405	0.00289	CcSEcCtD
Galantamine—Headache—Carmustine—malignant glioma	0.000403	0.00287	CcSEcCtD
Galantamine—Vomiting—Temozolomide—malignant glioma	0.000395	0.00282	CcSEcCtD
Galantamine—Rash—Temozolomide—malignant glioma	0.000392	0.00279	CcSEcCtD
Galantamine—Dermatitis—Temozolomide—malignant glioma	0.000391	0.00279	CcSEcCtD
Galantamine—Headache—Temozolomide—malignant glioma	0.000389	0.00277	CcSEcCtD
Galantamine—Nausea—Carmustine—malignant glioma	0.000382	0.00272	CcSEcCtD
Galantamine—Nausea—Temozolomide—malignant glioma	0.000369	0.00263	CcSEcCtD
Galantamine—BCHE—brain—malignant glioma	0.000364	0.00247	CbGeAlD
Galantamine—CYP3A4—central nervous system—malignant glioma	0.000309	0.0021	CbGeAlD
Galantamine—CYP2D6—central nervous system—malignant glioma	0.000304	0.00206	CbGeAlD
Galantamine—CYP2D6—cerebellum—malignant glioma	0.000297	0.00202	CbGeAlD
Galantamine—CYP2D6—brain—malignant glioma	0.000241	0.00164	CbGeAlD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000105	0.00118	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000105	0.00117	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000104	0.00117	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000104	0.00117	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000104	0.00116	CbGpPWpGaD
Galantamine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000103	0.00116	CbGpPWpGaD
Galantamine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000103	0.00116	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000102	0.00114	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—BRAF—malignant glioma	0.000101	0.00114	CbGpPWpGaD
Galantamine—CHRNA3—Transmission across Chemical Synapses—MDM2—malignant glioma	0.0001	0.00113	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—BRAF—malignant glioma	0.0001	0.00113	CbGpPWpGaD
Galantamine—CHRNA3—Transmission across Chemical Synapses—RAF1—malignant glioma	0.0001	0.00112	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—BCHE—malignant glioma	9.93e-05	0.00111	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	9.82e-05	0.0011	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	9.68e-05	0.00109	CbGpPWpGaD
Galantamine—CHRNA7—Transmission across Chemical Synapses—MDM2—malignant glioma	9.53e-05	0.00107	CbGpPWpGaD
Galantamine—CHRNA7—Transmission across Chemical Synapses—RAF1—malignant glioma	9.49e-05	0.00107	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—XBP1—malignant glioma	9.48e-05	0.00106	CbGpPWpGaD
Galantamine—ACHE—Phospholipid metabolism—PIK3CG—malignant glioma	9.47e-05	0.00106	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—MDM2—malignant glioma	9.43e-05	0.00106	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	9.41e-05	0.00106	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—RAF1—malignant glioma	9.4e-05	0.00105	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—SLC6A3—malignant glioma	9.33e-05	0.00105	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—BRAF—malignant glioma	9.27e-05	0.00104	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—BRAF—malignant glioma	9.18e-05	0.00103	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—MDM2—malignant glioma	8.96e-05	0.00101	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—RAF1—malignant glioma	8.93e-05	0.001	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—CXCL8—malignant glioma	8.86e-05	0.000994	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—VEGFA—malignant glioma	8.83e-05	0.00099	CbGpPWpGaD
Galantamine—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	8.72e-05	0.000978	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—TNF—malignant glioma	8.71e-05	0.000978	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—BRAF—malignant glioma	8.71e-05	0.000978	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—BRAF—malignant glioma	8.62e-05	0.000967	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	8.51e-05	0.000955	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL1B—malignant glioma	8.5e-05	0.000954	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—MDM2—malignant glioma	8.5e-05	0.000953	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—CASP3—malignant glioma	8.48e-05	0.000951	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—RAF1—malignant glioma	8.47e-05	0.00095	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—XBP1—malignant glioma	8.45e-05	0.000949	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PIK3CG—malignant glioma	8.44e-05	0.000948	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	8.41e-05	0.000944	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—MDM2—malignant glioma	8.41e-05	0.000944	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	8.4e-05	0.000943	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	8.39e-05	0.000942	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—RAF1—malignant glioma	8.38e-05	0.00094	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—SLC6A3—malignant glioma	8.33e-05	0.000934	CbGpPWpGaD
Galantamine—ACHE—Phospholipid metabolism—PIK3CD—malignant glioma	8.32e-05	0.000934	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—BRAF—malignant glioma	8.19e-05	0.000919	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	8.13e-05	0.000913	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—TP53—malignant glioma	7.97e-05	0.000894	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	7.94e-05	0.000891	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—MDM2—malignant glioma	7.77e-05	0.000871	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—RAF1—malignant glioma	7.74e-05	0.000868	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—MDM2—malignant glioma	7.69e-05	0.000863	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—RAF1—malignant glioma	7.67e-05	0.00086	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—TNF—malignant glioma	7.56e-05	0.000849	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	7.54e-05	0.000846	CbGpPWpGaD
Galantamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	7.51e-05	0.000843	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	7.5e-05	0.000841	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PIK3CD—malignant glioma	7.42e-05	0.000833	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—MDM2—malignant glioma	7.3e-05	0.000819	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	7.3e-05	0.000819	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—RAF1—malignant glioma	7.27e-05	0.000816	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7.26e-05	0.000814	CbGpPWpGaD
Galantamine—ACHE—Phospholipid metabolism—PIK3CB—malignant glioma	7.25e-05	0.000814	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—MDM2—malignant glioma	7.22e-05	0.000811	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	7.21e-05	0.00081	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—RAF1—malignant glioma	7.2e-05	0.000808	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—VEGFA—malignant glioma	7.19e-05	0.000807	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—BRAF—malignant glioma	7.1e-05	0.000797	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—SPHK1—malignant glioma	7.03e-05	0.000789	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTT1—malignant glioma	6.88e-05	0.000772	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—MDM2—malignant glioma	6.86e-05	0.00077	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—RAF1—malignant glioma	6.84e-05	0.000767	CbGpPWpGaD
Galantamine—ACHE—Metabolism—COX8A—malignant glioma	6.75e-05	0.000758	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—BRAF—malignant glioma	6.61e-05	0.000742	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PIK3CB—malignant glioma	6.47e-05	0.000726	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—PTGS1—malignant glioma	6.45e-05	0.000724	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	6.42e-05	0.00072	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	6.33e-05	0.00071	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—SPHK1—malignant glioma	6.27e-05	0.000704	CbGpPWpGaD
Galantamine—ACHE—Phospholipid metabolism—PTEN—malignant glioma	6.27e-05	0.000703	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—TNF—malignant glioma	6.17e-05	0.000692	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	6.14e-05	0.000689	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	6.04e-05	0.000678	CbGpPWpGaD
Galantamine—BCHE—Metabolism—COX8A—malignant glioma	6.03e-05	0.000676	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—MDM2—malignant glioma	5.95e-05	0.000668	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—RAF1—malignant glioma	5.93e-05	0.000665	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—BRAF—malignant glioma	5.9e-05	0.000662	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	5.83e-05	0.000655	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	5.75e-05	0.000645	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ASMT—malignant glioma	5.74e-05	0.000645	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	5.73e-05	0.000643	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	5.67e-05	0.000636	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.61e-05	0.00063	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PTEN—malignant glioma	5.59e-05	0.000627	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	5.56e-05	0.000624	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	5.54e-05	0.000622	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—MDM2—malignant glioma	5.54e-05	0.000622	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—RAF1—malignant glioma	5.52e-05	0.00062	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	5.49e-05	0.000616	CbGpPWpGaD
Galantamine—ACHE—Metabolism—BCAN—malignant glioma	5.4e-05	0.000606	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.39e-05	0.000604	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	5.14e-05	0.000577	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ASMT—malignant glioma	5.12e-05	0.000575	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—BRAF—malignant glioma	5.07e-05	0.000569	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—MDM2—malignant glioma	4.94e-05	0.000555	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—RAF1—malignant glioma	4.93e-05	0.000553	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—BCHE—malignant glioma	4.85e-05	0.000544	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	4.83e-05	0.000542	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—RTEL1—malignant glioma	4.82e-05	0.000541	CbGpPWpGaD
Galantamine—BCHE—Metabolism—BCAN—malignant glioma	4.82e-05	0.000541	CbGpPWpGaD
Galantamine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	4.81e-05	0.00054	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—FBXW7—malignant glioma	4.77e-05	0.000536	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTP1—malignant glioma	4.77e-05	0.000535	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	4.71e-05	0.000528	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—BRAF—malignant glioma	4.52e-05	0.000507	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	4.5e-05	0.000505	CbGpPWpGaD
Galantamine—ACHE—Phospholipid metabolism—PIK3CA—malignant glioma	4.42e-05	0.000496	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	4.37e-05	0.00049	CbGpPWpGaD
Galantamine—ACHE—Metabolism—IDH2—malignant glioma	4.35e-05	0.000488	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—FBXW7—malignant glioma	4.26e-05	0.000478	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—MDM2—malignant glioma	4.25e-05	0.000476	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—RAF1—malignant glioma	4.23e-05	0.000475	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	4.22e-05	0.000473	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.1e-05	0.000461	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP2B6—malignant glioma	4.09e-05	0.000459	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	4.02e-05	0.000451	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PIK3CA—malignant glioma	3.94e-05	0.000443	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.93e-05	0.000441	CbGpPWpGaD
Galantamine—BCHE—Metabolism—IDH2—malignant glioma	3.88e-05	0.000436	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—MDM2—malignant glioma	3.79e-05	0.000425	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—RAF1—malignant glioma	3.77e-05	0.000423	CbGpPWpGaD
Galantamine—ACHE—Metabolism—IDH1—malignant glioma	3.74e-05	0.00042	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3.74e-05	0.00042	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	3.71e-05	0.000416	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.66e-05	0.000411	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP2B6—malignant glioma	3.65e-05	0.00041	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SPHK1—malignant glioma	3.62e-05	0.000406	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP2C18—malignant glioma	3.55e-05	0.000398	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.41e-05	0.000383	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.35e-05	0.000375	CbGpPWpGaD
Galantamine—BCHE—Metabolism—IDH1—malignant glioma	3.34e-05	0.000375	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.3e-05	0.00037	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SPHK1—malignant glioma	3.23e-05	0.000363	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP2C18—malignant glioma	3.17e-05	0.000355	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—RTEL1—malignant glioma	3.15e-05	0.000354	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	3.12e-05	0.00035	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	3.08e-05	0.000345	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.05e-05	0.000342	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.99e-05	0.000335	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.94e-05	0.00033	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTT1—malignant glioma	2.87e-05	0.000322	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.79e-05	0.000313	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—COX8A—malignant glioma	2.77e-05	0.000311	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—F2—malignant glioma	2.75e-05	0.000309	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.72e-05	0.000305	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS1—malignant glioma	2.69e-05	0.000302	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.68e-05	0.000301	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.62e-05	0.000294	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTT1—malignant glioma	2.56e-05	0.000287	CbGpPWpGaD
Galantamine—ACHE—Metabolism—BCHE—malignant glioma	2.5e-05	0.000281	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SLC5A5—malignant glioma	2.47e-05	0.000277	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—F2—malignant glioma	2.46e-05	0.000275	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS1—malignant glioma	2.4e-05	0.000269	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.39e-05	0.000268	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ASMT—malignant glioma	2.36e-05	0.000264	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.34e-05	0.000262	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MMP2—malignant glioma	2.33e-05	0.000262	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.31e-05	0.00026	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—BCAN—malignant glioma	2.22e-05	0.000249	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC5A5—malignant glioma	2.2e-05	0.000247	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.08e-05	0.000234	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MMP2—malignant glioma	2.08e-05	0.000234	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.06e-05	0.000232	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.02e-05	0.000226	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTP1—malignant glioma	1.99e-05	0.000223	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—CXCL8—malignant glioma	1.94e-05	0.000218	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CAT—malignant glioma	1.94e-05	0.000217	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NCOR1—malignant glioma	1.83e-05	0.000205	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—COX8A—malignant glioma	1.81e-05	0.000203	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.8e-05	0.000202	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—IDH2—malignant glioma	1.79e-05	0.0002	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTP1—malignant glioma	1.77e-05	0.000199	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—CXCL8—malignant glioma	1.73e-05	0.000194	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CAT—malignant glioma	1.73e-05	0.000194	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.68e-05	0.000188	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NCOR1—malignant glioma	1.63e-05	0.000183	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ASMT—malignant glioma	1.54e-05	0.000173	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—IDH1—malignant glioma	1.54e-05	0.000172	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CAV1—malignant glioma	1.49e-05	0.000167	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SPHK1—malignant glioma	1.49e-05	0.000167	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.46e-05	0.000163	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—BCAN—malignant glioma	1.45e-05	0.000163	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.42e-05	0.00016	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CG—malignant glioma	1.36e-05	0.000152	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CAV1—malignant glioma	1.33e-05	0.000149	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PPARG—malignant glioma	1.31e-05	0.000147	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.27e-05	0.000143	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CG—malignant glioma	1.21e-05	0.000136	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CD—malignant glioma	1.19e-05	0.000134	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTT1—malignant glioma	1.18e-05	0.000132	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PPARG—malignant glioma	1.17e-05	0.000131	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—IDH2—malignant glioma	1.17e-05	0.000131	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS1—malignant glioma	1.1e-05	0.000124	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.1e-05	0.000123	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CD—malignant glioma	1.06e-05	0.000119	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CB—malignant glioma	1.04e-05	0.000117	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS2—malignant glioma	1.03e-05	0.000116	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—BCHE—malignant glioma	1.03e-05	0.000115	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.01e-05	0.000114	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—IDH1—malignant glioma	1e-05	0.000113	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SPHK1—malignant glioma	9.71e-06	0.000109	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP2C18—malignant glioma	9.52e-06	0.000107	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CB—malignant glioma	9.28e-06	0.000104	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS2—malignant glioma	9.19e-06	0.000103	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTEN—malignant glioma	8.99e-06	0.000101	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTP1—malignant glioma	8.16e-06	9.16e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTEN—malignant glioma	8.02e-06	9e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CAT—malignant glioma	7.94e-06	8.91e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTT1—malignant glioma	7.7e-06	8.64e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NCOR1—malignant glioma	7.5e-06	8.41e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS1—malignant glioma	7.21e-06	8.09e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—BCHE—malignant glioma	6.7e-06	7.52e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.62e-06	7.43e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CA—malignant glioma	6.34e-06	7.11e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CAV1—malignant glioma	6.11e-06	6.86e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CA—malignant glioma	5.66e-06	6.35e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.57e-06	6.25e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PPARG—malignant glioma	5.37e-06	6.03e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTP1—malignant glioma	5.33e-06	5.99e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CAT—malignant glioma	5.19e-06	5.83e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AKT1—malignant glioma	5.18e-06	5.81e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NCOR1—malignant glioma	4.9e-06	5.5e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.89e-06	5.49e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AKT1—malignant glioma	4.62e-06	5.19e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CB—malignant glioma	4.27e-06	4.79e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS2—malignant glioma	4.23e-06	4.74e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CAV1—malignant glioma	4e-06	4.48e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTEN—malignant glioma	3.69e-06	4.14e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.64e-06	4.08e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PPARG—malignant glioma	3.51e-06	3.94e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.2e-06	3.59e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.79e-06	3.13e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS2—malignant glioma	2.76e-06	3.1e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.6e-06	2.92e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTEN—malignant glioma	2.41e-06	2.7e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AKT1—malignant glioma	2.12e-06	2.38e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.7e-06	1.91e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AKT1—malignant glioma	1.39e-06	1.56e-05	CbGpPWpGaD
